NCT07169513 - Mechanistic Study of Anti-Platelet Therapy in Atherosclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions

Peripheral Arterial DiseaseSilent Atherosclerosis

Interventions

DRUG

Aspirin 75 mg daily

For group 1 patients

DRUG

Clopidogrel 75 mg daily

For group 2 patients

DRUG

Clopidgrel 75 mg daily

For group 1 patients

DRUG

Aspirin 75 mg daily + Clopidgrel 75 mg daily

For group 2 patients

Trial Locations (1)

Guy's and St Thomas' NHS Foundation Trust, London

All Listed Sponsors

collaborator

King's College London

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER